Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors

NCT06823609 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: QLS1304 tablet

Sponsor

Qilu Pharmaceutical Co., Ltd.